Regeneron pede autorização para distribuir medicamento que ...

Diário Digital - 08 Oct 2020
A empresa de biotecnologia Regeneron, proprietária do tratamento com que o Presidente dos EUA, Donald Trump, foi tratado à Covid-19, solicitou uma ...

Regeneron to collaborate on gene editing therapies with Doudna-founded Mammoth

Reuters - 25 Apr 2024
Regeneron to collaborate on gene editing therapies with Doudna-founded Mammoth ...

Regeneron signs Mammoth gene editing deal worth $100M upfront

Fierce Biotech - 25 Apr 2024
Regeneron signs Mammoth gene editing deal worth $100M upfront ...

Regeneron, Mammoth Launch In Vivo CRISPR Gene Editing Collaboration

Genetic Engineering & Biotechnology News - 25 Apr 2024
Regeneron, Mammoth Launch In Vivo CRISPR Gene Editing Collaboration ...

Regeneron and Mammoth announce gene editing partnership worth $370m per target

PMLiVE - 26 Apr 2024
Regeneron and Mammoth announce gene editing partnership worth $370m per target ...

Regeneron and Mammoth team up to develop gene editing therapies

Pharmaceutical Technology - 26 Apr 2024
Regeneron and Mammoth team up to develop gene editing therapies ...

Sales of Roche's juggernaut Vabysmo rout the analyst consensus

Fierce Pharma - 24 Apr 2024
Sales of Roche's juggernaut Vabysmo rout the analyst consensus ...

Sanofi vende participação na Regeneron por 13 mil milhões de dólares

Jornal de Negócios - 26 May 2020
Sanofi vende participação na Regeneron por 13 mil milhões de dólares ...

Regeneron Pharmaceuticals Inc. stock underperforms Friday when compared to competitors

MarketWatch - 26 Apr 2024
Regeneron Pharmaceuticals Inc. stock underperforms Friday when compared to competitors ...

AbbVie's Rinvoq shows superiority to Regeneron's Dupixent in study

XM - 25 Apr 2024
AbbVie's Rinvoq shows superiority to Regeneron's Dupixent in study ...

Regeneron inks $100M deal to develop gene-editing therapies

Crain's New York Business - 26 Apr 2024
Regeneron inks $100M deal to develop gene-editing therapies ...

Regeneron Bets $100M That Mammoth’s CRISPR Tech Can Deliver on Next Wave of Genetic Medicines

MedCity News - 25 Apr 2024
Regeneron Bets $100M That Mammoth’s CRISPR Tech Can Deliver on Next Wave of Genetic Medicines ...

Regeneron Pays Mammoth $100M to Access CRISPR Enzymes for AAV Delivery

BioSpace - 25 Apr 2024
Regeneron Pays Mammoth $100M to Access CRISPR Enzymes for AAV Delivery ...

Regeneron Fails to Quash Skin Cancer Drug Warning Suit (Correct)

Bloomberg Law - 26 Apr 2024
Regeneron Fails to Quash Skin Cancer Drug Warning Suit (Correct) ...

Regeneron Stock Under Microscope After DOJ Price Reporting Complaint—Key Levels to Watch

Investopedia - 11 Apr 2024
Regeneron Stock Under Microscope After DOJ Price Reporting Complaint—Key Levels to Watch ...

Head-to-head, it's AbbVie's Rinvoq over Regeneron's Dupixent

Fierce Pharma - 26 Apr 2024
Head-to-head, it's AbbVie's Rinvoq over Regeneron's Dupixent ...

AbbVie's skin disease drug found to be more effective than Regeneron's Dupixent in study

Reuters - 25 Apr 2024
AbbVie's skin disease drug found to be more effective than Regeneron's Dupixent in study ...

Regeneron builds new venture arm with $500M commitment to invest in biotech and beyond

Fierce Biotech - 15 Apr 2024
Regeneron builds new venture arm with $500M commitment to invest in biotech and beyond ...

Regeneron to defend against DOJ complaint on drug-price manipulation

Reuters - 15 Apr 2024
Regeneron to defend against DOJ complaint on drug-price manipulation ...

Regeneron hit with DOJ complaint that it hid 'hundreds of millions' in Eylea credit card processing fees from Medicare

Fierce Pharma - 11 Apr 2024
Regeneron hit with DOJ complaint that it hid 'hundreds of millions' in Eylea credit card processing fees from Medicare ...

Regeneron